Sandhill Scientific Markets New Gastro Diagnostic Tools
HIGHLANDS RANCH, Colo. - Officials from Sandhill Scientific have announced Food and Drug Administration (FDA) approval to market two new modalities for the diagnosis of gastrointestinal disorders.
The MultiChannel Intraluminal Impedance technology was designed to allow characterization of bolus movement within the esophagus. The technology is to be paired with traditional pressure manometry as part of a new device and diagnostic test referred to as esophageal function testing (EFT). It will also be used with a traditional pH ambulatory device that determines reflux episodes.
For additional information, log on to: www.sandhillsci.com.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
